Mark Siegler to Drugs, Investigational
This is a "connection" page, showing publications Mark Siegler has written about Drugs, Investigational.
Connection Strength
0.229
-
Inside information: Financial conflicts of interest for research subjects in early phase clinical trials. J Natl Cancer Inst. 2004 May 05; 96(9):656-61.
Score: 0.229